Study Validates ARFID Screening Tool for Gastroenterology Patients

Research demonstrates the efficacy of the Nine-Item ARFID Screen for identifying avoidant/restrictive food intake disorder (ARFID) in patients with disorders of gut-brain interaction (DGBI). The findings indicate that while the screening tool is highly sensitive, care must be taken in interpreting elevated scores.

Want to explore the research behind this topic?Search the NPRL

Understanding Disorders of Gut-Brain Interaction

Disorders of gut-brain interaction encompass conditions such as functional constipation, functional dyspepsia, and irritable bowel syndrome, impacting around 40% of adults. For many individuals suffering from these disorders, their relationship with food can become fraught due to gastrointestinal triggers and symptoms, which may lead to avoidant behaviors akin to ARFID.

Research Overview and Screening Tool Calibration

A recent study, co-led by Dr. Allen Lee at Michigan Medicine, sought to refine the Nine-Item ARFID Screen to better serve patients experiencing DGBI. At a screening cutoff score of 22, the tool showed a sensitivity of 94.6% and a negative predictive value of 97.6%. However, its positive predictive value was identified at only 43.8%. This emphasizes that while a higher score alerts healthcare providers to potential ARFID, it does not confirm a diagnosis.

The Prevalence of ARFID in Patients with DGBI

Previous estimates of ARFID prevalence among patients with DGBI have varied significantly. A population-based study reported positive screening rates of 34.6% among adults, while some investigations of specific GI populations reported rates over 50%. In the study cohort, 47.3% screened positive, yet clinical assessments indicated that only 23.7% were classified as having possible or probable ARFID. This data suggests that screening tools may inflate ARFID prevalence, but a more accurate assessment would require structured clinical evaluations.

Screening tools may inflate ARFID prevalence, but a more accurate assessment would require structured clinical evaluations.

Implications for Future Dietary Interventions

The research underscores the importance of screening before recommending restrictive dietary interventions, such as the low-FODMAP diet, especially given the nuanced relationship between gastrointestinal symptoms and eating behaviors. Adjusting the screening threshold to a cutoff score of 22 improves sensitivity and helps identify individuals who may benefit from further evaluation, rather than establishing a definitive diagnosis on its own.

THE CNP TAKEAWAY

Early identification of ARFID in patients with gastrointestinal disorders is essential. This study highlights the importance of using validated screening tools and ensuring comprehensive evaluations before implementing restrictive diets.